URI ELKAYAM

Chairmanships

Chairman of a Symposium: "Vasodilator therapy: does it make a difference?" Fall Symposium, American Heart Association - Greater Los Angeles Affiliate. Los Angeles, California, September, 1982.

Chairman of a Symposium: "Cardiac problems in pregnancy," 51st Annual Fall Symposium, American Heart Association - Greater Los Angeles Affiliate. Los Angeles, California, September, 1983.

Chairman of a Symposium: "Pregnancy in the patients with cardiac disease," at the 33rd Annual Scientific Session of the American College of Cardiology. Dallas, Texas, March, 1984.

Session Chairman: Postgraduate Course "Medical complications of pregnancy." Rush Medical College, Chicago, Illinois, November, 1984.

Session Moderator: Young Investigator's Forum, American Heart Association, Los Angeles Affiliate. Los Angeles, California, May, 1985.

Session Chairman: "Clinical Cardiology," 6th European Congress on Diseases of the Chest. Tel Aviv, Israel, June, 1986.

Postgraduate Course Director: "Update in new and old cardiovascular drug therapy," University of Southern California, Los Angeles, California, April, 1987.

Postgraduate Course Director: "Cardiovascular Drug Therapy II" - University of Southern California, Los Angeles, California, June, 1988.

Session Chairman: "Heart failure: drugs and devices," 61st Scientific Sessions of the American Heart Association, Washington, DC, November, 1988.

Session Chairman: "Nitrate Tolerance," 62nd Scientific Sessions of the American Heart Association, New Orleans, Louisiana, November, 1989.

Session Moderator: "Acute ischemic syndrome/pathophysiology and management," Fall Symposium, American Heart Association - Greater Los Angeles Affiliate, Los Angeles, California, September, 1990.

Session Moderator: "When does therapy in heart failure prolong survival?" Fall Symposium,American Heart Association - Greater Los Angeles Affiliate, Los Angeles, California, September, 1991.

Course Director: "Hypertension and heart failure: risk factors, prevention and treatment". University of Southern California, School of Medicine, Pasadena, California, May, 1992.

Session Chairman: "Heart failure - flosequinan." 65th Scientific Sessions of the American Heart Association, New Orleans, LA. November 1992.

Session Chairman: "Heart failure - beta blockers." 65th Scientific Sessions of the American Heart Association, New Orleans, LA. November 1992.

Course Director: "Congestive Heart Failure: Management in the 90's." University of Southern California School of Medicine, Los Angeles, CA. January 1993.

Session Co-Chairman: "Pathophysiology." 2nd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 19, 1993.

Session Co-Chairman: "Hypertrophy, Hypertension." 2nd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 21, 1993.

Course Director: "Management of Heart Failure: 1993." University of Southern California School of Medicine, Pasadena, CA. June 1993.

Course Director: "From ischemia to heart failure: Management strategies," University of Southern California School of Medicine, Pasadena, CA. February 1994.

Session Co-Chairman: "How to manage end-stage heart failure," Meet the Experts Session, American College of Cardiology, 43rd Annual Scientific Session, Atlanta, GA. March 1994.

Session Co-Chairman: "Cardiovascular Clinical Pharmacology," American College of Cardiology, 43rd Annual Scientific Session. March 1994.

Symposium Chairman: "Nitrates in Heart Failure." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995.

Session Co-Chairman: "Renal aspects, diuretics." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995.

Session Co-Chairman: "Vascular biology." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995.

Co-Chairman: "Nitrates." 6th International Symposium on Cardiovascular Pharmacotherapy. Sydney, Australia, February 29, 1996.

Session Co-Chairman: "Calcium antagonists and promoters." 4th International Symposium on Heart Failure - Mechanisms and Management. Jerusalem, Israel, May 27, 1996.

Co-Chairman: "Nitrates, vasodilators and newer drugs." 4th International Symposium on Heart Failure - Mechanisms and Management. Jerusalem, Israel, May 27, 1996.

Co-Chairman: "The treatment of congestive heart failure." 9th Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery. Tel Aviv, Israel, October 23, 1996.

Moderator - How to Session: "Pregnancy and heart disease" in the 69th Annual Scientific Sessions of the American Heart Association. New Orleans, Louisiana, November 11, 1996.

Program Director - Postgraduate Program: "Congestive heart failure 1997. Can care be improved at reduced cost?" University of Southern California. Pasadena, California,March 1, 1997.

Co-Chairman - Meet the Experts Session: "Heart disease during pregnancy" in the 46th Annual Scientific Session American College of Cardiology. Anaheim, California,March 16-19, 1997.

Chairman: Opening lecture in 5th world congress on heart failure mechanisms and management. Washington, D.C., May 11-14, 1997.

Co-Chairman: "Calcium channel blockers and promoters" in the 5th world congress on heart failure - mechanisms and management. Washington, D.C., May 11-14, 1997.

Co-Chairman - State of the art session: "Congestive heart failure and beta blockers" in the 7^th International symposium on cardiovascular pharmacology. Jerusalem, Israel, June 1-5, 1997.

Moderator, Symposium on Treatment Strategies, First Annual Scientific Meeting, Heart Failure Society of America. Baltimore, Maryland. September 21-24, 1997.

Moderator Scientific Session on Heart Failure: pathophysiologic, hemodynamic, metabolic, and energetic factors. 70th Scientific Session, American Heart Association, Orlando, Florida, November 9-12, 1997.

Moderator-How-To-Session "How to manage the patients with adult congenital heart disease: an emerging population." 70th Scientific Session, American Heart Association, Orlando, Florida, November 9-12, 1997.

Program Director: Postgraduate Program. Congestive Heart Failure 1998: Update on prevention and treatment.@ University of Southern California, Pasadena, California, January 24, 1998.

Chairman, State of the Art Session - Management of heart failure in the CCU. International Meeting Intensive Cardiac Care. Jerusalem, Israel, June 30, 1998.

Program Director, Postgraduate program “Heart Failure 1999—an Update on Therapy,” University of Southern California, Los Angeles, California, January 1999.

Chairman: Plenary Session “Natriuretic Peptides, Endothelin: Role in Heart Failure, Washington, DC. In 1

Chairman: Plenary Session “Natriuretic Peptides, Endothelin: Role in Heart Failure,” Washington, DC. May 19, 1999.

Moderator, Session on adverse and differential effects of heart failure therapy. 72

Program Director, Postgraduate program “Heart Failure 2000—an Update on Therapy.” University of Southern California, Los Angeles, California, January 29, 2000.

Chairman, Scientific Executive Committee and Chairman, Section on Clinical Trials. 7

Chairperson, Opening Ceremony. 7

viagra black market in canada

microzide online without prescription

^th World Congress on Heart Failure - Mechanisms and Management. Vancouver, B.C., Canada, July 9-12, 2000.

Chairperson, Plenary Session "Cardiomyopathies: Hypertrophic and Dilated." 7

aristocort drug generic

buy adderall by phone without a prescription

^th World Congress on Heart Failure - Mechanisms and Management. Vancouver, B.C. Canada, July 9-12, 2000.

Program Director, Postgraduate program “Heart Failure 2001—an Update on Therapy.” University of Southern California. Pasadena, California, January 27, 2001.

Moderator, Luncheon Panel on “Heart Failure: New Treatments.” 69^th Annual Fall Symposium, American Heart Association, September 15, 2001.

Program Director, postgraduate program “Heart Failure 2002 – An Update on Therapy.” University of Southern California. Pasadena, California, January 26, 2002.

Chair, “Natriuretic peptides in management.” Heart Failure Down Under, World Congress of Cardiology Satellite Meeting. Auckland, New Zealand, May 11-12, 20022.

Chair, “New treatment for decompensated heart failure – results of clinical trials and their clinical implications.” 3^rd International Meeting – Intensive Cardiac Care. Jerusalem, Israel, June 26, 2002.

Fall Symposium Chair, American Heart Association 70

purchase aciphex without script next day delivery

cheap leukeran tablets

^th Annual Fall Symposium “Cardiology 2002 – An Update on Diagnosis and Therapy.” Los Angeles, California, October 12, 2002.

URI ELKAYAM, M.D.
Home Biosketch Personal Info Education Professional Info Society Memberships Consultanships Editorial Boards Honors&Awards School Thesis
Chairmanships Chairman of a Symposium: "Vasodilator therapy: does it make a difference?" Fall Symposium, American Heart Association - Greater Los Angeles Affiliate. Los Angeles, California, September, 1982. Chairman of a Symposium: "Cardiac problems in pregnancy," 51st Annual Fall Symposium, American Heart Association - Greater Los Angeles Affiliate. Los Angeles, California, September, 1983. Chairman of a Symposium: "Pregnancy in the patients with cardiac disease," at the 33rd Annual Scientific Session of the American College of Cardiology. Dallas, Texas, March, 1984. Session Chairman: Postgraduate Course "Medical complications of pregnancy." Rush Medical College, Chicago, Illinois, November, 1984. Session Moderator: Young Investigator's Forum, American Heart Association, Los Angeles Affiliate. Los Angeles, California, May, 1985. Session Chairman: "Clinical Cardiology," 6th European Congress on Diseases of the Chest. Tel Aviv, Israel, June, 1986. Postgraduate Course Director: "Update in new and old cardiovascular drug therapy," University of Southern California, Los Angeles, California, April, 1987. Postgraduate Course Director: "Cardiovascular Drug Therapy II" - University of Southern California, Los Angeles, California, June, 1988. Session Chairman: "Heart failure: drugs and devices," 61st Scientific Sessions of the American Heart Association, Washington, DC, November, 1988. Session Chairman: "Nitrate Tolerance," 62nd Scientific Sessions of the American Heart Association, New Orleans, Louisiana, November, 1989. Session Moderator: "Acute ischemic syndrome/pathophysiology and management," Fall Symposium, American Heart Association - Greater Los Angeles Affiliate, Los Angeles, California, September, 1990. Session Moderator: "When does therapy in heart failure prolong survival?" Fall Symposium,American Heart Association - Greater Los Angeles Affiliate, Los Angeles, California, September, 1991. Course Director: "Hypertension and heart failure: risk factors, prevention and treatment". University of Southern California, School of Medicine, Pasadena, California, May, 1992. Session Chairman: "Heart failure - flosequinan." 65th Scientific Sessions of the American Heart Association, New Orleans, LA. November 1992. Session Chairman: "Heart failure - beta blockers." 65th Scientific Sessions of the American Heart Association, New Orleans, LA. November 1992. Course Director: "Congestive Heart Failure: Management in the 90's." University of Southern California School of Medicine, Los Angeles, CA. January 1993. Session Co-Chairman: "Pathophysiology." 2nd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 19, 1993. Session Co-Chairman: "Hypertrophy, Hypertension." 2nd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 21, 1993. Course Director: "Management of Heart Failure: 1993." University of Southern California School of Medicine, Pasadena, CA. June 1993. Course Director: "From ischemia to heart failure: Management strategies," University of Southern California School of Medicine, Pasadena, CA. February 1994. Session Co-Chairman: "How to manage end-stage heart failure," Meet the Experts Session, American College of Cardiology, 43rd Annual Scientific Session, Atlanta, GA. March 1994. Session Co-Chairman: "Cardiovascular Clinical Pharmacology," American College of Cardiology, 43rd Annual Scientific Session. March 1994. Symposium Chairman: "Nitrates in Heart Failure." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995. Session Co-Chairman: "Renal aspects, diuretics." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995. Session Co-Chairman: "Vascular biology." 3rd International Symposium on Heart Failure - Mechanisms and Management. Geneva, Switzerland, May 22, 1995. Co-Chairman: "Nitrates." 6th International Symposium on Cardiovascular Pharmacotherapy. Sydney, Australia, February 29, 1996. Session Co-Chairman: "Calcium antagonists and promoters." 4th International Symposium on Heart Failure - Mechanisms and Management. Jerusalem, Israel, May 27, 1996. Co-Chairman: "Nitrates, vasodilators and newer drugs." 4th International Symposium on Heart Failure - Mechanisms and Management. Jerusalem, Israel, May 27, 1996. Co-Chairman: "The treatment of congestive heart failure." 9th Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery. Tel Aviv, Israel, October 23, 1996. Moderator - How to Session: "Pregnancy and heart disease" in the 69th Annual Scientific Sessions of the American Heart Association. New Orleans, Louisiana, November 11, 1996. Program Director - Postgraduate Program: "Congestive heart failure 1997. Can care be improved at reduced cost?" University of Southern California. Pasadena, California,March 1, 1997. Co-Chairman - Meet the Experts Session: "Heart disease during pregnancy" in the 46th Annual Scientific Session American College of Cardiology. Anaheim, California,March 16-19, 1997. Chairman: Opening lecture in 5th world congress on heart failure mechanisms and management. Washington, D.C., May 11-14, 1997. Co-Chairman: "Calcium channel blockers and promoters" in the 5th world congress on heart failure - mechanisms and management. Washington, D.C., May 11-14, 1997. Co-Chairman - State of the art session: "Congestive heart failure and beta blockers" in the 7^th International symposium on cardiovascular pharmacology. Jerusalem, Israel, June 1-5, 1997. Moderator, Symposium on Treatment Strategies, First Annual Scientific Meeting, Heart Failure Society of America. Baltimore, Maryland. September 21-24, 1997. Moderator Scientific Session on Heart Failure: pathophysiologic, hemodynamic, metabolic, and energetic factors. 70th Scientific Session, American Heart Association, Orlando, Florida, November 9-12, 1997. Moderator-How-To-Session "How to manage the patients with adult congenital heart disease: an emerging population." 70th Scientific Session, American Heart Association, Orlando, Florida, November 9-12, 1997. Program Director: Postgraduate Program. Congestive Heart Failure 1998: Update on prevention and treatment.@ University of Southern California, Pasadena, California, January 24, 1998. Chairman, State of the Art Session - Management of heart failure in the CCU. International Meeting Intensive Cardiac Care. Jerusalem, Israel, June 30, 1998. Program Director, Postgraduate program “Heart Failure 1999—an Update on Therapy,” University of Southern California, Los Angeles, California, January 1999. Chairman: Plenary Session “Natriuretic Peptides, Endothelin: Role in Heart Failure, Washington, DC. In 1 how to get protopic penlac without a prescription ^st International Congress on heart disuse, new trends in research, diagnosis and treatment. May 16-19, 1999. Chairman: Plenary Session “Natriuretic Peptides, Endothelin: Role in Heart Failure,” Washington, DC. May 19, 1999. Moderator, Session on adverse and differential effects of heart failure therapy. 72 cheap piroxicam no rx tricor drug generic show ^nd Scientific Session, American Heart Association. Atlanta, Georgia, November 1999. Program Director, Postgraduate program “Heart Failure 2000—an Update on Therapy.” University of Southern California, Los Angeles, California, January 29, 2000. Chairman, Scientific Executive Committee and Chairman, Section on Clinical Trials. 7 purchase aciphex without script next day delivery cheap leukeran tablets ^th World Congress on Heart Failure - Mechanisms and Management. Vancouver, B.C. Canada, July 9-12, 2000. Chairperson, Opening Ceremony. 7^th World Congress on Heart Failure - Mechanisms and Management. Vancouver, B.C., Canada, July 9-12, 2000. Chairperson, Plenary Session "Cardiomyopathies: Hypertrophic and Dilated." 7^th World Congress on Heart Failure - Mechanisms and Management. Vancouver, B.C. Canada, July 9-12, 2000. Program Director, Postgraduate program “Heart Failure 2001—an Update on Therapy.” University of Southern California. Pasadena, California, January 27, 2001. Moderator, Luncheon Panel on “Heart Failure: New Treatments.” 69^th Annual Fall Symposium, American Heart Association, September 15, 2001. Moderator, “Unconventional approaches – tomorrow’s headlines?” 18 how to get protopic penlac without a prescription ^th Annual Santa Fe Colloquium on Cardiovascular Therapy of the American College of Cardiology, Santa Fe, New Mexico, October 5, 2001. Program Director, postgraduate program “Heart Failure 2002 – An Update on Therapy.” University of Southern California. Pasadena, California, January 26, 2002. Chair, “Natriuretic peptides in management.” Heart Failure Down Under, World Congress of Cardiology Satellite Meeting. Auckland, New Zealand, May 11-12, 20022. Chair, “New treatment for decompensated heart failure – results of clinical trials and their clinical implications.” 3^rd International Meeting – Intensive Cardiac Care. Jerusalem, Israel, June 26, 2002. Fall Symposium Chair, American Heart Association 70^th Annual Fall Symposium “Cardiology 2002 – An Update on Diagnosis and Therapy.” Los Angeles, California, October 12, 2002. viagra black market in canada microzide online without prescription

USC Cardiovascular Medicine, 1200 North State Street, Room 7621, LA, CA 90033. Ph:323 226 7541 get a aygestin without prescription where can i buy valtrex online show